REFERENCES
1. Li N, Li Y, Cui L, et al. Association between different stages of cardiovascular-kidney-metabolic syndrome and the risk of all-cause mortality. Atherosclerosis. 2024;397:118585.
2. Paavonsalo S, Hariharan S, Lackman MH, Karaman S. Capillary rarefaction in obesity and metabolic diseases - organ-specificity and possible mechanisms. Cells. 2020;9:2683.
3. Kida Y. Peritubular capillary rarefaction: an underappreciated regulator of CKD progression. Int J Mol Sci. 2020;21:8255.
4. Bentley MD, Rodriguez-porcel M, Lerman A, et al. Enhanced renal cortical vascularization in experimental hypercholesterolemia. Kidney Int. 2002;61:1056-63.
5. Chade AR, Krier JD, Galili O, Lerman A, Lerman LO. Role of renal cortical neovascularization in experimental hypercholesterolemia. Hypertension. 2007;50:729-36.
6. Hull KL, Adenwalla SF, Topham P, Graham-brown MP. Indications and considerations for kidney biopsy: an overview of clinical considerations for the non-specialist. Clin Med. 2022;22:34-40.
7. Erdbrügger U, Blijdorp CJ, Bijnsdorp IV, et al. Urinary extracellular vesicles: a position paper by the urine task force of the international society for extracellular vesicles. J Extracellular Vesicle. 2021;10:e12093.
8. Svenningsen P, Sabaratnam R, Jensen BL. Urinary extracellular vesicles: origin, role as intercellular messengers and biomarkers; efficient sorting and potential treatment options. Acta Physiol. 2019;228:e13346.
9. Schnobrich L, Castrop H. Urinary microvesicles: a window into the kidney. Clinical Kidney Journal. 2025;18:sfaf189.
10. Zhang L, Al-saeedi M, Denic A, et al. Renal podocyte senescence in human obesity detected by urinary extracellular vesicles. eBioMedicine. 2026;124:106116.
11. Sun IO, Santelli A, Abumoawad A, et al. Loss of renal peritubular capillaries in hypertensive patients is detectable by urinary endothelial microparticle levels. Hypertension. 2018;72:1180-8.
12. Puranik AS, Leaf IA, Jensen MA, et al. Kidney-resident macrophages promote a proangiogenic environment in the normal and chronically ischemic mouse kidney. Sci Rep. 2018;8:13948.
13. Zhang B, Liang H, Yu Z, Wei F, Wu Y. Clinical implications of estimating glomerular filtration rate with different equations in heart failure patients with preserved ejection fraction. High Blood Press Cardiovasc Prev. 2024;31:205-13.
14. Dinsdale G, Moore T, O'leary N, et al. Intra-and inter-observer reliability of nailfold videocapillaroscopy - a possible outcome measure for systemic sclerosis-related microangiopathy. Microvasc Res. 2017;112:1-6.
15. Lamah M, Chaudhry H, Mortimer P, Dormandy J. Repeatability of intravital capillaroscopic measurement of capillary density. Int J Microcirc. 1996;16:23-9.
16. Van Der Weijden J, De Hoogt PA, Leufkens MME, et al. The relationship of peritubular capillary density with glomerular volume and kidney function in living kidney donors. J Nephrol. 2023;36:2111-24.
17. Issa N, Lopez CL, Denic A, et al. Kidney structural features from living donors predict graft failure in the recipient. J Am Soc Nephrol. 2020;31:415-23.
18. Asghar MS, Denic A, Mullan AF, et al. Age-based versus young-adult thresholds for nephrosclerosis on kidney biopsy and prognostic implications for CKD. J Am Soc Nephrol. 2023;34:1421-32.
19. Pellegrini D, Konst R, Van Den Oord S, et al. Features of atherosclerosis in patients with angina and no obstructive coronary artery disease. EuroIntervention. 2022;18:e397-404.
20. Owusu J, Barrett E. Early microvascular dysfunction: is the vasa vasorum a “missing link” in insulin resistance and atherosclerosis. Int J Mol Sci. 2021;22:7574.
21. Son J, Li S, Jeong W. Bioprinting vascularized constructs for clinical relevance: engineering hydrogel systems for biological maturity. Gels. 2025;11:636.
22. Oosthuyzen W, Scullion KM, Ivy JR, et al. Vasopressin regulates extracellular vesicle uptake by kidney collecting duct cells. J Am Soc Nephrol. 2016;27:3345-55.
23. Chatterjee E, Rodosthenous RS, Kujala V, et al. Circulating extracellular vesicles in human cardiorenal syndrome promote renal injury in a kidney-on-chip system. JCI Insight. 2023;8:e165172.
24. Ståhl A, Arvidsson I, Johansson KE, et al. A novel mechanism of bacterial toxin transfer within host blood cell-derived microvesicles. PLoS Pathog. 2015;11:e1004619.
25. Mohammadlou M, Salehi S, Baharlou R. Development of anti DLL4 Nanobody fused to truncated form of Pseudomonas exotoxin: as a novel immunotoxin to inhibit of cell proliferation and neovascularization. Anal Biochem. 2022;653:114776.
26. Tefft JB, Bays JL, Lammers A, Kim S, Eyckmans J, Chen CS. Notch1 and Notch3 coordinate for pericyte-induced stabilization of vasculature. Am J Physiol Cell Physiol. 2022;322:C185-96.
27. Wang R, Sun Q, Wu X, et al. Hypoxia as a double-edged sword to combat obesity and comorbidities. Cells. 2022;11:3735.
28. Liu Y, Xu K, Xiang Y, et al. Role of MCP-1 as an inflammatory biomarker in nephropathy. Front. Immunol. 2024;14:1303076.
29. Kwaifa IK, Bahari H, Yong YK, Noor SM. Endothelial dysfunction in obesity-induced inflammation: molecular mechanisms and clinical implications. Biomolecules. 2020;10:291.
30. Lin H, Fu L, Zhou X, et al. LRP1 induces anti-PD-1 resistance by modulating the DLL4-NOTCH2-CCL2 axis and redirecting M2-like macrophage polarisation in bladder cancer. Cancer Lett. 2024;593:216807.
31. Li M, Wang M, Wen Y, Zhang H, Zhao GN, Gao Q. Signaling pathways in macrophages: molecular mechanisms and therapeutic targets. MedComm. 2023;4:e349.
32. Chen Y, Dabbas W, Gangemi A, et al. Obesity management and chronic kidney disease. Semin Nephrol. 2021;41:392-402.
33. Kounatidis D, Vallianou NG, Stratigou T, Voukali M, Karampela I, Dalamaga M. The kidney in obesity: current evidence, perspectives and controversies. Curr Obes Rep. 2024;13:680-702.
34. Krishnan S, Suarez‐martinez AD, Bagher P, et al. Microvascular dysfunction and kidney disease: Challenges and opportunities? Microcirculation 2020;28:e12661.
35. Jang KW, Hur J, Lee DW, Kim SR. Metabolic syndrome, kidney-related adiposity, and kidney microcirculation: unraveling the damage. Biomedicines. 2024;12:2706.
36. Mohandes S, Doke T, Hu H, Mukhi D, Dhillon P, Susztak K. Molecular pathways that drive diabetic kidney disease. J Clin Investig. 2023;133:e165654.
37. Zhang A, Fang H, Chen J, He L, Chen Y. Role of VEGF-A and LRG1 in abnormal angiogenesis associated with diabetic nephropathy. Front. Physiol. 2020;11:1064.
38. Zhang X, Lerman LO. Obesity and renovascular disease. Am J Physiol Renal Physiol. 2015;309:F273-9.
39. Li S, Wang F, Sun D. The renal microcirculation in chronic kidney disease: novel diagnostic methods and therapeutic perspectives. Cell Biosci. 2021;11:90.
